Cytokine profiles in nasal fluid in patients with nasal polyps: A flow cytometric study

Journal of Medical Biochemistry

Volumn 29, Issue 1, 2010, Pages 28-33

  Perić, Aleksandar ^a   Vojvodić, Danilo ^a   Radulović, Vesna ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Municipal Institute for Lung Diseases and Tuberculosis   (Serbia)

Author keywords

Alergija; Allergy; Asthma; Astma; Citokini; Cytokines; Nasal fluid; Nasal polyps; Nosni polipi; Nosni sekret

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ALLERGY; ARTICLE; ASTHMA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; NOSE CAVITY; NOSE MUCUS; NOSE POLYP; NOSE SECRETION;

EID: 77749273810     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0003-1     Document Type: Article

References (25)

1. Král B, Krejsek J, Paráková Z, Kopecký O, Vokurková D, Derner V, et al. Some serum activity markers of airways inflammation in difficult-to-control asthma patients. Acta Medica (Hradec Králové) 1997; 40: 61-70.
2. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; 45 (Suppl 20): 1-136.
3. Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg 2007; 133: 705-9.
4. Carpagnano GE, Resta O, Gelardi M, Spanevello A, Di Gioia G, Giliberti T, et al. Exhaled inflammatory markers in aspirin-induced asthma syndrome. Am J Rhinol 2007; 21: 542-7.
5. Ramanathan M, Lee WK, Spannhake EW, Lane A P. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 2008; 22: 115-21.
6. Jankowski R, Persoons M, Foliguet B, Coffinet L, Thomas C, Verient-Montaut B. Eosinophil count in nasal se-cretions of subjects with and without nasal symptoms. Rhinology 2000; 38: 23-32.
7. Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Bürner H. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005; 35: 1186-91.
8. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M. Biological markers in nasal secretions. Eur Respir J 2003; 21: 600-5.
9. Bousquet J. Global Initiative for Asthma (GINA) and its objectives. Clin Exp Allergy 2000; 30 (Suppl 1): 2-5.
10. Tsicopoulos A, Shimbara A, De Nadai P, Aldewachi O, Lamblin C, Lassalle P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004; 113: 462-9.
11. Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997; 117: 465-7.
12. Watelet JB, Gevaert P, Holtappels G, Van Cauwenberge P, Bachert C. Collection of nasal secretions for immunological analysis. Eur Arch Otorhinolaryngol 2004; 261: 242-6.
13. Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118: 375-9.
14. Ohkubo K, Masakazu I, Pawankar R, Gotoh M, Yagi T, Okuda M. Mechanisms of IL-6, IL-8 and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology 1998; 36: 156-61.
15. Hens G, Hellings PW. The nose: gatekeeper and trigger of bronchial disease. Rhinology 2006; 44: 179-87.
16. Rinia AB, Kostamo K, Ebbens FA, Van Drunen CM, Fok kens WJ. Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007; 62: 348-58.
17. Bachert C, Wagenmann M, Rudack C, Höpken K, Hillebrandt M, Wang D, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998; 53: 2-13.
18. Hamilos DL, Leung DJ, Wood R, Cunningham L, Bean DK, Yasruel Z, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995; 96; 537-44.
19. Liu CM, Hong CY, Shun C T, Hsiao TY, Wang CC, Wang JS, et al. Inducible cyclooxygenase and interleukin-6 ge ne expression in nasal polyp fibroblasts. Arch Otolaryngol Head Neck Surg 2002; 128: 945-51.
20. Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114: 981-3.
21. Hellings PW, Hens G, Meyts I, Bullens D, Vanoirbeek J, Gevaert P, et al. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy 2006; 36: 1063-71.
22. Xu G, Xia JH, Zhou H, Yu CZ, Zhang Y, Zuo KJ, et al. Interleukin-6 is essential for Staphylococcal exotoxin B-induced T regulatory cell insufficiency in nasal polyps. Clin Exp Allergy 2009; 39: 829-37.
23. Dellacono FR, Eisma R, Lafreniere D, Leonard G, Kretzer D. Interferon-gamma expression in human nasal polyps. Laryngoscope 1997; 107: 626-30.
24. Ohori J, Ushikai M, Sun D, Nishimoto K, Sagara Y, Fukuiwa T, et al. TNF-α upregulates VCAM-1 and NF-κB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007; 34: 177-83.
25. Van Pelt J, Romijn F. Long-term Quality Control of the cytokine α growth factors and cell adhesion molecule arrays at the Randox Evidence Investigator. Journal of Medical Biochemistry 2009; 28: 300-304.